Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05626426 · ClinicalTrials.gov registry record · NA
Electrical Stimulation for the Treatment of Optic Neuropathies
A NA study of Glaucoma and Glaucoma Open-Angle, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05626426: Recruiting NA study of Glaucoma and Glaucoma Open-Angle, sponsored by Stanford University.
NCT05626426 is a NA study of Glaucoma and Glaucoma Open-Angle that is actively recruiting participants, run by Stanford University. The registered enrollment target is 40 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05626426, a NA study of Glaucoma and Glaucoma Open-Angle, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.
Conditions Studied
Interventions
- DEVICE Repetitive, Transorbital Alternating Current Stimulation (rtACS)
Study Locations (1)
California
- Byers Eye Institute - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-02-27 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT05626426 shows while recruiting
NCT05626426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Repetitive, Transorbital Alternating Current Stimulation (rtACS) is the first listed.
NCT05626426 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05626426 about?
NCT05626426 is a clinical study titled "Electrical Stimulation for the Treatment of Optic Neuropathies". The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your e...
What is the current status of trial NCT05626426?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-02-27. Estimated completion is 2027-12.
What conditions does trial NCT05626426 study?
This clinical trial studies the following conditions: Glaucoma, Glaucoma Open-Angle, Optic Nerve Diseases.
What interventions are being tested in trial NCT05626426?
The interventions under investigation include: Repetitive, Transorbital Alternating Current Stimulation (rtACS) (DEVICE).
Who is sponsoring clinical trial NCT05626426?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05626426 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05626426's enrollment target sits among peer trials
40 74th of 92 higher than 17 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Hyperbaric Oxygen Therapy for Optic Neuropathies
RECRUITING · NA
-
Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI